Workflow
Oncolytic viral immunotherapy
icon
Search documents
FIRST LIGHT ACQU(FLAG) - Prospectus
2024-12-12 11:13
Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 2834 Primary Standard Industrial Classification Code Number Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (IRS Employer Identification No.) Delaware 86-2967193 4475 Executive Drive, Suite 200 San Diego, CA 92121 (858) 794-9600 (Address, including zip code, and telepho ...
FIRST LIGHT ACQU(FLAG) - Prospectus(update)
2024-04-15 10:31
As filed with the Securities and Exchange Commission on April 15, 2024. Registration No. 333-276741 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Delaware 2834 86-2967193 (I.R.S. Employer Identification No.) 4475 Executive Driv ...
Calidi Biotherapeutics(CLDI) - Prospectus
2024-01-29 14:32
As filed with the Securities and Exchange Commission on January 29, 2024. Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 86-2967193 4475 Executive Drive, Suite 200, (I.R.S. Employer Ident ...
Calidi Biotherapeutics(CLDI) - Prospectus(update)
2024-01-16 11:31
As filed with the Securities and Exchange Commission on January 16, 2024. Registration No. 333-274885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 86-2967193 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifi ...
Calidi Biotherapeutics(CLDI) - Prospectus(update)
2024-01-08 11:31
As filed with the Securities and Exchange Commission on January 8, 2024. Registration No. 333-274885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 86-2967193 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identific ...
Calidi Biotherapeutics(CLDI) - Prospectus
2023-10-06 00:47
As filed with the Securities and Exchange Commission on October 6, 2023. Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Calidi Biotherapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 86-2967193 (I.R.S. Employer Identification No.) 4475 Executive Driv ...
Genelux (GNLX) - Prospectus(update)
2023-01-10 02:25
Table of Contents As filed with the Securities and Exchange Commission on January 9, 2023. Registration No. 333-265828 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Genelux Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 77-0583529 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer ...